Across the recent three months, 9 analysts have shared their insights on Clorox CLX, expressing a variety of opinions spanning from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 0 | 7 | 1 | 1 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 0 | 3 | 1 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 1 |
3M Ago | 0 | 0 | 3 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Clorox, presenting an average target of $153.89, a high estimate of $170.00, and a low estimate of $136.00. This current average represents a 1.04% decrease from the previous average price target of $155.50.
Analyzing Analyst Ratings: A Detailed Breakdown
A comprehensive examination of how financial experts perceive Clorox is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Wendy Nicholson | Citigroup | Lowers | Neutral | $155.00 | $165.00 |
Lauren Lieberman | Barclays | Lowers | Underweight | $136.00 | $148.00 |
Wendy Nicholson | Citigroup | Lowers | Neutral | $165.00 | $170.00 |
Dara Mohsenian | Morgan Stanley | Maintains | Equal-Weight | $160.00 | $160.00 |
Kaumil Gajrawala | Jefferies | Announces | Hold | $145.00 | - |
Bonnie Herzog | Goldman Sachs | Announces | Sell | $140.00 | - |
Linda Bolton Weiser | DA Davidson | Announces | Neutral | $162.00 | - |
Peter Grom | UBS | Raises | Neutral | $170.00 | $145.00 |
Andrea Teixeira | JP Morgan | Raises | Neutral | $152.00 | $145.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Clorox. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Clorox compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
Capture valuable insights into Clorox's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Clorox analyst ratings.
Discovering Clorox: A Closer Look
Since its inception more than 100 years ago, Clorox has grown to play in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just shy of 85% of Clorox's sales stem from its home turf.
Breaking Down Clorox's Financial Performance
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Clorox displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately 16.04%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Staples sector.
Net Margin: Clorox's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 4.67%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Clorox's ROE excels beyond industry benchmarks, reaching 1162.5%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Clorox's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.56%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Clorox's debt-to-equity ratio surpasses industry norms, standing at 59.04. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
How Are Analyst Ratings Determined?
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.